准备好使用和粉末阿博托毒素A对骨线的比较:一个随机的,受控的,三盲临床试验
Silvio Ventura da Silva Junior1, Maria Luiza Boechat Borges Neves1, Alfonso Sanchez-Ayala2
1Department of Dentistry, Ingá University Center, Uningá, Maringá, Paraná, Brazil.
Journal of cosmetic dermatology
|June 23, 2025
概括
准备好使用的肉毒素A (RTUaboBoNT-A) 的疗效和耐用性与标准的肉毒素A在 glabellar 线上具有可比性. 虽然这两种治疗都是安全的,但RTUaboBoNT-A与注射疼痛增加有关.
科学领域:
- 皮肤病学 皮肤病学
- 审美医学是一种美学医学.
- 神经学 神经学
背景情况:
- 玻尿酸毒素A (BoNT-A) 是一种用于治疗白斑线的领先治疗方法.
- 关于准备使用的abobotulinumtoxinA (RTUaboBoNT-A) 对这种化品适用性的有效性存在有限的数据.
研究的目的:
- 为了比较RTUaboBoNT-A与标准abobotulinumtoxinA (aboBoNT-A) 的疗效,耐用性和安全性.
- 评估RTUaboBoNT-A用于治疗中度至重度的纹.
主要方法:
- 一个随机的,三盲试验,涉及38名25-50岁的男性志愿者.
- 参与者接受aboBoNT-A或RTUaboBoNT-A,评估包括EMG,纹严重程度尺度和患者满意度.
- 在注射前和注射后1,2,3,4个月收集的数据.
主要成果:
- 在任何随访点,RTUaboBoNT-A和aboBoNT-A之间在EMG活性或皮线严重性方面没有发现显著差异.
- 两个治疗组之间的患者满意度水平是可比的.
- RTUaboBoNT-A组在注射过程中报告了明显更高的疼痛强度.
结论:
- RTUaboBoNT-A的疗效和耐用性与标准aboBoNT-A在 glabellar线治疗中的疗效和耐用性相当.
- 这两种配方都被认为是安全的,尽管RTUaboBoNT-A可能会增加注射不适.
- RTUaboBoNT-A提供了一个可行的替代方案,用于 glabellar纹纠正.
更多相关视频
相关概念视频
Blinding
3.2K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.2K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
774
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
774
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.7K


